India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

In $20 million Series A fundraise of KULT, IJ represented investors

IJ acts for AC Ventures in investment in InnerGize, a mental healthtech

IJ acts for investor in $3 million round of GROWiT

Publications

Structuring of Angel Funds in GIFT City

Launching SM REITs in India

Setting up Funds in GIFT City

Newsletters

RBI Circular on Basel III – Reinstating Unrestricted Use of BRIPL Ratings for Capital Adequacy

SEBI’s Validated UPI Framework: A Stronger Shield for Investor Funds

SEBI’s Framework for Environment, Social and Governance (ESG) Debt Securities